Search results

52 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
ASPIRE Research: Autism and Irritability Study
ASPIRE is conducting a research study for 6 to 17 year olds who experience irritability related to autism. The study is looking at an investigational medication called lurasidone to find out whether it is safe and effective in managing irritability in children and teenagers with autism.
Located in Vital Signs / 2014 / July 24
Is It ADHD? Looking At Signs and Symptoms
One in 10 children age 5-17 in the U.S. is diagnosed with Attention Deficit Hyperactive Disorder (ADHD), but sometimes the signs are very tough to spot. Dr. Daniel Moran gives some insights on what parents should look for.
Located in UNC Children's News / News / 2017
Adult Male Autism Study: ASPIRE Research
The goal of this study is to measure the effects of an investigational drug on social behavior, communication, and safety. Study for adult males, ages 18-45, with high functioning autism.
Located in Vital Signs / 2014 / June 26
UNC to launch unprecedented collaboration to improve services for young children with autism and their families
Multiple programs at UNC to utilize $900,000 grant from the U.S. Department of Health and Human Services
Located in News / 2014 / January
TEACCH Autism Program receives $120,000 grant from Autism Speaks
Principal investigator Mark Klinger, and co-investigator, Laura Klinger, will assess the effectiveness of the TEACCH School Transition to Employment Program (TSTEP) for adolescents and young adults (ages 16 – 21) with ASD.
Located in Vital Signs / 2014 / Jan. 9
UNC research tabbed as a top autism breakthrough of 2013
The work of Mark Zylka, PhD, and Ben Philpot, PhD, is featured by Autism Speaks in its list of 10 major advances in autism research in 2013.
Located in News / 2013 / December
UNC child neurologist finds potential route to better treatments for Fragile X, autism
C.J. Malanga discovered that three specific drugs affect three different kinds of neurotransmitter receptors that all seem to play roles in Fragile X Syndrome.
Located in News / 2013 / October
A New Frontier
Once unknown in the field of autism, UNC’s Mark Zylka is now uncovering potential causes for the brain disorder.
Located in News / 2013 / October
Researchers discover how a chemical used in chemotherapies affects genes linked to autism
Key enzymes are found to have a ‘profound effect’ across dozens of genes linked to autism. The insight could help illuminate environmental factors behind autism spectrum disorder and contribute to a unified theory of how the disorder develops.
Located in News / 2013 / August
UNC autism research featured on WRAL
Joseph Piven, MD, professor of psychiatry, director of the Carolina Institute for Developmental Disabilities, was interviewed by WRAL for a story about the link between eye movement and autism.
Located in Vital Signs / 2013 / May 30